Fernando Meton de Alencar Câmara Vieira
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Colorectal Cancer Surgical Treatments, Gastric Cancer Management and Outcomes, Colorectal and Anal Carcinomas, Genetic factors in colorectal cancer
Most-Cited Works
- → Randomized Phase III Trial of Single-Agent Pemetrexed Versus Carboplatin and Pemetrexed in Patients With Advanced Non–Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status of 2(2013)237 cited
- → Nonoperative management of rectal cancer after chemoradiation opposed to resection after complete clinical response. A comparative study(2015)141 cited
- → Diretriz Brasileira de Cardio-oncologia – 2020(2020)91 cited
- → Phase 1 study of cetuximab in combination with 5‐fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma(2013)66 cited
- → KRAS mutations: variable incidences in a Brazilian cohort of 8,234 metastatic colorectal cancer patients(2014)42 cited
- → A randomized phase III trial of single-agent pemetrexed (P) versus carboplatin and pemetrexed (CP) in patients with advanced non-small cell lung cancer (NSCLC) and performance status (PS) of 2.(2012)27 cited
- → Survival and prognostic factors in patients with Non-Small Cell Lung Cancer treated in private health care(2014)23 cited
- → GUIDELINE FOR THE MANAGEMENT OF BILE DUCT CANCERS BY THE BRAZILIAN GASTROINTESTINAL TUMOR GROUP(2016)6 cited
- → Quality of life in a randomized trial comparing two neoadjuvant regimens for locally advanced rectal cancer—INCAGI004(2022)3 cited
- → Colorectal cancer biomarkers and their impact on the clinical practice(2021)3 cited